Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

BACKGROUND: Warfarin reduces ischemic stroke risk in atrial fibrillation (AF) but increases bleeding risk. Novel anticoagulants challenge warfarin as stroke‐preventive therapy for AF. They are available at fixed doses but are more costly. Warfarin anticoagulation at a time in therapeutic range (TTR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dallalzadeh, Liane O., Go, Alan S., Chang, Yuchiao, Borowsky, Leila H., Fang, Margaret C., Singer, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015384/
https://www.ncbi.nlm.nih.gov/pubmed/27451456
http://dx.doi.org/10.1161/JAHA.116.003482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015384/
https://www.ncbi.nlm.nih.gov/pubmed/27451456
http://dx.doi.org/10.1161/JAHA.116.003482

Ejemplares similares